INTRODUCTION {#S1}
============

The glutamatergic subthalamic nucleus (STN) is part of the basal ganglia, a group of subcortical brain nuclei critical for movement and a key site of pathology in Parkinson's disease (PD) ([@R2]). The STN is a component of the so-called hyperdirect and indirect pathways, which contribute to the execution of action sequences through elevation of GABAergic basal ganglia output ([@R43]; [@R30]; [@R60]; [@R38]). In PD, increases in the frequency and synchronization of STN activity have been linked to the expression of akinesia, bradykinesia, and rigidity ([@R71]; [@R57]; [@R53]). However, PD motor symptoms are ameliorated by both inhibition of STN activity through lesions ([@R6]) or pharmacological/optogenetic approaches ([@R33]; [@R70]) and elevation of STN activity through direct electrical stimulation ([@R5]; [@R67]). In addition, therapeutic dopamine (DA) receptor activation and STN deep brain stimulation decorrelate but do not necessarily diminish STN activity ([@R24]; [@R16]). Together these data argue that an abnormal pattern rather than frequency of STN activity is particularly detrimental to movement in PD.

In toxin models of PD, abnormal STN activity takes days to weeks to manifest, suggesting that plasticity triggered by loss of DA contributes to its emergence ([@R63]; [@R37]). Indeed, recent studies showed that the strength of external globus pallidus (GPe) inhibition relative to cortical excitation of the STN quadruples through proliferation and removal of GPe and cortical synapses, respectively ([@R11]; [@R39]; [@R12]). In parallel, the intrinsic autonomous firing of STN neurons is strongly downregulated ([@R73]; [@R69]). The available evidence suggests that increased inhibition of the GPe by D2-striatal projection neurons (D2-SPNs) leads to disinhibition of the STN and excessive activation of STN N-methyl-D-aspartate receptors (NMDARs), triggering synaptic plasticity ([@R11], [@R12]). Although the cause of autonomous firing downregulation is unknown, it may be triggered by a similar mechanism because NMDAR activation can produce oxidant stress and opening of K~ATP~ channels, which hyperpolarize STN neurons and inhibit their spiking ([@R4]). Autonomous firing is thought to underlie the resting, tonic discharge of STN neurons *in vivo* and thus support their function as a "driving force" of extrastriatal basal ganglia activity ([@R28]; [@R7]; [@R42]; [@R14]). Autonomous spiking also influences the synaptic patterning of STN activity because the responses to inputs are related to the frequency and timing of the postsynaptic firing cycle ([@R9]; [@R68]). Thus, the loss of autonomous firing together with plastic alterations in the strength of synaptic input may contribute to the emergence of abnormal STN activity in PD. Using the unilateral 6-hydroxydopamine (6-OHDA)-lesion model of PD, we therefore addressed the underlying mechanisms and functional consequences of downregulated autonomous STN activity.

RESULTS {#S2}
=======

Data are reported as median and interquartile ranges. Unpaired data are represented as boxplots, with the median, interquartile range, and 10%--90% range denoted. Paired data are represented as tilted line-segment plots. Non-parametric, two-tailed statistical tests were applied: Mann-Whitney U (MWU) test for unpaired data, Wilcoxon signed rank (WSR) test for paired comparisons, and Fisher's exact test for contingency analyses. p values were corrected for multiple comparisons ([@R25]) ([Tables S1](#SD1){ref-type="supplementary-material"}-[S8](#SD1){ref-type="supplementary-material"}).

Autonomous STN Activity Is Downregulated in DA-Depleted Mice {#S3}
------------------------------------------------------------

Previous studies have demonstrated that autonomous STN activity is downregulated in toxin models of PD ([@R73]; [@R69]; [@R12]). Furthermore, STN neurons identified as receiving input from the primary motor cortex also exhibited decreased activity ([@R12]). We first confirmed the result of [@R12] using an identical approach, but a more extensive sample. Thus, the autonomous activities of STN neurons that were excited by optogenetic stimulation of motor cortical axon terminals were compared in *ex vivo* brain slices from mice that had received unilateral injection of 6-OHDA or vehicle into the medial forebrain bundle (MFB). The cell-attached, current-clamp configuration of the patch clamp technique was used to record autonomous activity without perturbation. In concordance with earlier reports, the frequency, regularity, and incidence of autonomous STN firing was reduced in slices from 6-OHDA-injected DA-depleted mice ([Figures 1](#F1){ref-type="fig"} and [S1A](#SD1){ref-type="supplementary-material"}; [Table S1](#SD1){ref-type="supplementary-material"}). Thus, loss of DAergic neuromodulation leads to the downregulation of autonomous activity in the motor territory of the STN.

Elevation of D2-SPN Transmission Is Sufficient to Downregulate Autonomous STN Activity {#S4}
--------------------------------------------------------------------------------------

In PD and its experimental models, loss of striatal DAergic innervation disinhibits D2-SPNs, which increases inhibition of the GPe, which in turn disinhibits the STN ([@R35]; [@R32]; [@R54]; [@R45]; [@R49]). This change in circuit activity triggers alterations in the strength of synaptic transmission in the STN ([@R11], [@R12]). We therefore hypothesized that the downregulation of autonomous STN activity is similarly triggered by Parkinsonian circuit activity. However, SN DA neurons also directly and positively modulate STN firing ([@R73], [@R74]; [@R34]; [@R47]) arguing that reduced STN activity in PD models may result from loss of local DA signaling. To determine whether an increase in D2-SPN activity is sufficient to downregulate autonomous firing in the STN, D2-SPNs were chemogenetically stimulated in DA-intact adora2A-rM3D(Gs)-mCherry mice that express rM3D(Gs)-mCherry in D2-SPNs ([@R17]). Consistent with chemogenetic activation of D2-SPNs in these mice (1) subcutaneous (s.c.) administration of 1 mg/kg clozapine-N-oxide (CNO) reduces both GPe activity *in vivo* and movement in the open field ([@R17]; [@R12]; [@R10]) and (2) application of 10 μM of CNO elevates the frequency of GABAergic synaptic currents in GPe neurons *ex vivo* ([@R12]). We found that the frequency, regularity, and incidence of autonomous STN activity in *ex vivo* brain slices from CNO-treated adora2A-rM3D(Gs)-mCherry mice (1 mg/kg s.c. every 12 h for 60 h) was reduced relative to activity in slices from vehicle-treated adora2A-rM3D(Gs)-mCherry mice ([Figures 2A](#F2){ref-type="fig"}-[2D](#F2){ref-type="fig"}; [Table S2](#SD1){ref-type="supplementary-material"}). In regular C57BL/6 mice that lacked designer receptor exclusively activated by designer drug (DREADD) expression, the same schedule of CNO administration had no effect ([Figures S1B](#SD1){ref-type="supplementary-material"} and [S1C](#SD1){ref-type="supplementary-material"}; [Tables S1](#SD1){ref-type="supplementary-material"} and [S2](#SD1){ref-type="supplementary-material"}), consistent with a recent report showing no non-specific effect of CNO on basal ganglia circuit activity ([@R10]). Together these data demonstrate that elevation of D2-SPN transmission is *sufficient* to downregulate autonomous STN activity.

If elevated striato-pallidal transmission and subsequent disinhibition of the STN underlie the downregulation of autonomous STN activity in 6-OHDA-treated mice, a corollary is that the effect of chemogenetic activation of D2-SPNs should be occluded by DA depletion. To test this prediction, adora2A-rM3D(Gs)-mCherry mice were injected unilaterally in the MFB with either 6-OHDA or vehicle. Approximately 2--3 weeks later, mice received s.c. injections of either vehicle or CNO (as above) and the autonomous activity of STN neurons from the hemisphere ipsilateral to MFB injection was analyzed *ex vivo*. Consistent with this prediction, the effect of D2-SPN chemogenetic stimulation on autonomous STN activity was occluded by DA depletion, as evinced by the similarity of data from MFB 6-OHDA-injected mice that received s.c. vehicle or CNO treatment ([Figures 2E](#F2){ref-type="fig"} and [2F](#F2){ref-type="fig"}; [Table S2](#SD1){ref-type="supplementary-material"}).

NMDARs Are Necessary for the Downregulation of Autonomous STN Activity in PD Mice {#S5}
---------------------------------------------------------------------------------

In 6-OHDA-injected mice, disinhibition of the STN leads to NMDAR-dependent alterations in the strength of synaptic transmission ([@R11], [@R12]). Furthermore, pre-incubation of brain slices from DA-intact mice with 25 μM of NMDA persistently downregulates autonomous STN activity ([@R4]). Therefore, we hypothesized that the loss of autonomous STN spiking in 6-OHDA-injected mice is due to increased activation of STN NMDARs *in vivo*. To test this hypothesis, STN NMDARs were knocked down by stereotaxic injection of an adeno-associated virus (AAV) carrying a cre recombinase expression construct into the STN of mice in which *GRIN1*, the gene encoding the obligatory subunit of the NMDAR, was floxed ([@R62]; [@R11], [@R12]) ([Figures 3A](#F3){ref-type="fig"}-[3D](#F3){ref-type="fig"}; [Table S3](#SD1){ref-type="supplementary-material"}). As a control, another set of these mice received injection of an AAV expressing only eGFP ([Figures 3A](#F3){ref-type="fig"}-[3D](#F3){ref-type="fig"}; [Table S3](#SD1){ref-type="supplementary-material"}). Viral injections were performed at the same time as 6-OHDA or vehicle injection in the MFB. Consistent with our hypothesis, STN NMDAR knockdown (KD) prevented the downregulation of autonomous STN activity in 6-OHDA-injected mice ([Figures 3C](#F3){ref-type="fig"} and [3D](#F3){ref-type="fig"}; [Table S3](#SD1){ref-type="supplementary-material"}). If activation of STN NMDARs *in vivo* is responsible for the downregulation of autonomous STN activity in 6-OHDA-injected mice, then a corollary is that the downregulatory effect of NMDAR activation *ex vivo* ([@R4]) should be occluded in slices from 6-OHDA-injected but not vehicle-injected C57BL/6 mice. Consistent with this prediction, NMDAR activation *ex vivo* downregulated autonomous STN activity in slices from vehicle- but not 6-OHDA-injected mice relative to untreated slices ([Figures 3E](#F3){ref-type="fig"} and [3F](#F3){ref-type="fig"}; [Table S3](#SD1){ref-type="supplementary-material"}).

STN Neurons Exhibit Elevated Oxidant Stress and Hydrogen Peroxide-Triggered K~ATP~ Channel Activation in PD Mice {#S6}
----------------------------------------------------------------------------------------------------------------

NMDAR activation can stimulate opening of ATP-sensitive K^+^ (K~ATP~) channels, which limit the firing of STN neurons ([@R55]; [@R4]). NMDAR activation can promote K~ATP~ channel opening through a fall in the ratio of ATP to ADP ([@R44]; [@R65]) or the generation of reactive oxygen (ROS) and/or reactive nitrogen species (RNS), which act directly ([@R26]; [@R27]; [@R31]; [@R4]) or indirectly via second messenger pathways ([@R55]; [@R72]). To determine whether NMDAR-dependent downregulation of autonomous STN firing in 6-OHDA-injected mice is dependent on activation of K~ATP~ channels, we conducted a series of experiments. To test whether disinhibition of STN neurons in 6-OHDA-injected mice is associated with elevated oxidant stress, we virally expressed the mitochondrial persistent downregulation of autonomous spiking ([@R4]) ([Table S4](#SD1){ref-type="supplementary-material"}).

To determine whether elevated production of ROS is linked to the downregulation of autonomous STN activity, membrane permeable catalase, which metabolizes hydrogen peroxide, was applied. Catalase application rapidly reversed the firing deficit in slices from 6-OHDA-injected mice ([Figures 4C](#F4){ref-type="fig"} and [4D](#F4){ref-type="fig"}; [Table S4](#SD1){ref-type="supplementary-material"}). This treatment also modestly increased firing in slices from vehicle-injected mice, although the effects were smaller. To determine whether K~ATP~ channels are responsible for downregulated STN activity, we compared the effect of the K~ATP~ channel inhibitor glibenclamide (100 nM) on autonomous firing in slices from 6-OHDA- and vehicle-injected mice. Glibenclamide rescued autonomous activity in slices from 6-OHDA-injected mice. Although this treatment also modestly increased the frequency and regularity of firing in slices from vehicle-injected mice, the effects were smaller ([Figures 4E](#F4){ref-type="fig"} and [4F](#F4){ref-type="fig"}; [Table S4](#SD1){ref-type="supplementary-material"}). The effects of catalase or K~ATP~ channel inhibition on spiking were similar, implying that they were mediated through a common pathway ([Figure 4G](#F4){ref-type="fig"}; [Table S4](#SD1){ref-type="supplementary-material"}). Consistent with this inference, the effects of catalase were fully occluded by prior application of glibenclamide ([Figures 4H](#F4){ref-type="fig"} and [4I](#F4){ref-type="fig"}; [Table S4](#SD1){ref-type="supplementary-material"}).

To determine whether ATP depletion was also a factor, the spiking rate in cell-attached recordings was compared to that after breaking into the cell with an internal solution containing 2 mM of ATP. Dialysis with ATP did not change spiking in neurons from lesioned mice, arguing that ATP depletion did not contribute ([Figures 4J](#F4){ref-type="fig"} and [4K](#F4){ref-type="fig"}; [Table S4](#SD1){ref-type="supplementary-material"}). Finally, we tested whether the downregulation of autonomous STN firing produced by chemogenetic stimulation of D2-SPNs was also mediated through K~ATP~ channels. Consistent with this mechanism, glibenclamide rescued autonomous STN firing in slices from CNO-treated mice but had minimal effects in vehicle-treated mice ([Figures S2A](#SD1){ref-type="supplementary-material"} and [S2B](#SD1){ref-type="supplementary-material"}; [Table S4](#SD1){ref-type="supplementary-material"}). Together, the data argue that following the loss of DA, disinhibition of the STN leads to increased activation of STN NMDARs, which increases ROS-triggered K~ATP~ channel opening, resulting in the downregulation of autonomous firing.

It was recently reported that expression of small-conductance Ca^2+^-activated K^+^ (SK) channels, which are important regulators of autonomous STN activity ([@R22]), is upregulated in 6-OHDA-injected rodents ([@R41]). To determine their role, the effect of 10 nM of apamin (an SK channel blocker) was examined. The effects of SK channel blockade were negligible in 6-OHDA- (and vehicle-) injected mice, arguing that SK channels are not responsible for the downregulation of autonomous activity in 6-OHDA-injected mice ([Figure S3](#SD1){ref-type="supplementary-material"}; [Table S4](#SD1){ref-type="supplementary-material"}).

Chemogenetic Restoration of Autonomous STN Activity Ameliorates Motor Dysfunction in PD Mice {#S7}
--------------------------------------------------------------------------------------------

To gain insight into the effect of autonomous firing loss on motor function in PD mice, we first determined whether intrinsic STN activity could be restored through direct chemogenetic activation ([@R48]) ([Figures 5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}, and [7](#F7){ref-type="fig"}; [Tables S5](#SD1){ref-type="supplementary-material"}, [S6](#SD1){ref-type="supplementary-material"}, and [S7](#SD1){ref-type="supplementary-material"}). An AAV vector carrying a synapsin promoter-driven hM3D(Gq)-mCherry construct was injected into the STN ipsilateral to MFB injection of 6-OHDA or vehicle ([Figure 5A](#F5){ref-type="fig"}). Two to three weeks matrix-targeted thiol redox sensor mito-roGFP in STN neurons ([@R23]; [@R21]; [@R4]). 2-photon laser scanning microscopic imaging of mito-roGFP confirmed that mitochondrial oxidant stress was increased in STN neurons in slices from 6-OHDA-injected mice (the dynamic range of the sensor was similar in slices from 6-OHDA- and vehicle-injected mice; [Figures 4A](#F4){ref-type="fig"} and [4B](#F4){ref-type="fig"}; [Table S4](#SD1){ref-type="supplementary-material"}). Mitochondrial oxidant stress was also elevated in STN neurons in slices from DA-intact mice that were pre-treated with a concentration of exogenous NMDA that induces the later the effect of chemogenetically activating hM3D(Gq)-mCherry through administration of 10 μM of CNO was tested *ex vivo*. CNO application increased the frequency and regularity of autonomous activity in hM3D(Gq)-mCherry-expressing STN neurons in slices from both 6-OHDA- and vehicle-injected mice, presumably through the generation of a persistent inward current that could be measured under voltage clamp at −60 mV ([Figures 5B](#F5){ref-type="fig"}-[5E](#F5){ref-type="fig"}; [Table S5](#SD1){ref-type="supplementary-material"}). These effects occurred within a minute of CNO application and persisted for the remainder of the recording, which was usually a further 10--30 min. Administration of CNO to slices from DA-intact mice that did not express hM3D(Gq)-mCherry had no effect on autonomous activity, ruling out off-target effects of CNO ([Figure S4](#SD1){ref-type="supplementary-material"}; [Table S5](#SD1){ref-type="supplementary-material"}). In addition, no effect on the amplitude or short-term plasticity of electrically evoked postsynaptic currents in hM3D(Gq)-mCherry-expressing STN neurons was observed ([Figures 5F](#F5){ref-type="fig"} and [5G](#F5){ref-type="fig"}; [Table S5](#SD1){ref-type="supplementary-material"}). Together these data demonstrate that chemogenetic activation of hM3D(Gq)-mCherry rapidly and persistently restores autonomous STN activity in 6-OHDA-injected mice with no effect on afferent synaptic transmission.

Given the voltage- and time-dependent properties of STN neuron ion channels and neurotransmitter receptors, the impact of synaptic input is exquisitely sensitive to the presence, frequency, and timing of postsynaptic autonomous activity ([@R8]; [@R68]). Therefore, to determine whether chemogenetic restoration of autonomous firing affected synaptic integration in STN neurons, responses to optogenetic stimulation of their motor cortical inputs were compared before and after chemogenetic activation of hM3D(Gq)-mCherry in *ex vivo* brain slices from 6-OHDA-injected mice. ChR2(H134R)-eYFP was virally expressed in motor cortical projections to the STN through AAV injection in the motor cortex, as described previously ([@R11], [@R12]). Two to three weeks later *ex vivo* brain slices were prepared and cortical inputs were stimulated using 1-ms duration blue light pulses delivered at 20 Hz for 1 s ([Figures 5H](#F5){ref-type="fig"} and [5I](#F5){ref-type="fig"}). The number of "synaptically driven" action potentials was defined as the number of spikes that exceeded the mean + 3 SD of spikes in the second prior to stimulation ([Figure 5J](#F5){ref-type="fig"}). Chemogenetic restoration of autonomous STN activity reduced the amount of synaptically driven activity both in absolute terms and as a fraction of the total number of intrinsically and extrinsically generated spikes ([Figures 5H](#F5){ref-type="fig"}-[5J](#F5){ref-type="fig"}). These data confirm that restoration of autonomous STN activity in PD mice profoundly alters the impact of synaptic inputs on STN activity.

Given that chemogenetic activation of STN neurons rescued their intrinsic activity and modified the impact of synaptic inputs that have been implicated in patterning Parkinsonian activity ([@R71]; [@R57]; [@R53]), we hypothesized that chemogenetic activation of STN neurons *in vivo* would ameliorate motor dysfunction in PD mice. To confirm chemogenetic activation of STN neurons in hM3D(Gq)-mCherry expressing vehicle- or 6-OHDA-injected mice *in vivo*, CNO (s.c., 1 mg/kg) or vehicle was administered and 90 min later, mice were perfused-fixed and then processed for immunohistochemical detection of (1) *c-fos*, a protein whose expression is linked to elevated neuronal activity ([@R40]), and (2) parvalbumin, a Ca^2+^-binding protein that can be used to identify GABAergic neurons in the SN ([@R46]). Consistent with the chemogenetic activation of the STN, the density of STN neurons that expressed *c-fos* was elevated in tissue from CNO-treated mice ([Figures 6A](#F6){ref-type="fig"}-[6C](#F6){ref-type="fig"}; [Table S6](#SD1){ref-type="supplementary-material"}). Furthermore, the density of PV-immunoreactive SNr neurons that expressed *c-fos* was increased in tissue from CNO-treated mice, consistent with the chemogenetic elevation of synaptic input from the STN ([Figures 6D](#F6){ref-type="fig"}-[6F](#F6){ref-type="fig"}; [Table S6](#SD1){ref-type="supplementary-material"}). The impact of chemogenetic activation of the STN on motor function was then assessed using the "cylinder test" ([@R52]). When placed in a small-diameter cylinder, rodents explore their vertical environment by rearing upward and in so doing place their forelimbs on the side of the cylinder. In unilateral MFB vehicle-injected, DA-intact mice forelimb contacts with the side of the cylinder were symmetric, and chemogenetic stimulation of the STN (s.c., 1 mg/kg of CNO) had no consistent effect ([Figures 7A](#F7){ref-type="fig"} and [7B](#F7){ref-type="fig"}; [Table S7](#SD1){ref-type="supplementary-material"}). However, in unilateral MFB 6-OHDA-injected, DA-depleted rodents, forelimb usage was asymmetric. Forelimb use contralateral to toxin injection was reduced relative to the ipsilateral forelimb and also to contralateral forelimb use in MFB vehicle-injected, DA-intact mice ([@R52]) ([Figures 7A](#F7){ref-type="fig"}-[7D](#F7){ref-type="fig"}; [Table S7](#SD1){ref-type="supplementary-material"}). Within 30 min of chemogenetic stimulation (s.c., 1 mg/kg of CNO), unilateral 6-OHDA-injected mice with ipsilateral STN hM3D(Gq)-mCherry expression increased their usage of the contralateral Parkinsonian forelimb *and* decreased their usage of the ipsilateral forelimb relative to baseline ([Figure 7C](#F7){ref-type="fig"}; [Table S7](#SD1){ref-type="supplementary-material"}; [Video S1](#SD2){ref-type="supplementary-material"}). Twenty-four hours following CNO injection, forelimb usage had returned to its asymmetric state (data not shown). In unilateral MFB 6-OHDA-injected, DA-depleted mice, with hM3D(Gq)-mCherry expressed ipsilaterally in regions adjacent to but not including the STN, chemogenetic stimulation modestly increased contralateral forelimb usage ([Figure 7D](#F7){ref-type="fig"}; [Table S7](#SD1){ref-type="supplementary-material"}). However, the rescue of forelimb usage following STN chemogenetic stimulation was greater than that produced by stimulation of surrounding structures ([Figure 7E](#F7){ref-type="fig"}; [Table S7](#SD1){ref-type="supplementary-material"}). Administration of CNO to MFB 6-OHDA-injected, DA-depleted mice without hM3D(Gq)-mCherry expression had no effect on forelimb usage ([Figure S5](#SD1){ref-type="supplementary-material"}; [Table S7](#SD1){ref-type="supplementary-material"}), ruling out a non-specific effect of CNO ([@R10]). Together these data demonstrate that the chemogenetic rescue of autonomous STN activity in unilateral 6-OHDA-injected mice improved usage of the contralateral Parkinsonian forelimb during vertical exploratory behavior.

DISCUSSION {#S8}
==========

Autonomous firing is a fundamental property of STN neurons that supports their resting excitation of the extrastriatal basal ganglia ([@R28]; [@R7]; [@R42]; [@R14]; [@R3]) and influences the manner in which STN activity is patterned by synaptic input ([@R8]; [@R68]). Here, we studied the cellular and circuit mechanisms that underlie the loss of autonomous STN firing in the 6-OHDA model of PD and the functional consequences of chemogenetically restoring this intrinsic activity.

In PD models, loss of inhibitory D2 receptor-dependent neuromodulation leads to an increase in the frequency and synchronization of D2-SPN output ([@R35]; [@R32]; [@R54]; [@R45]; [@R49]). These changes have been attributed to disinhibition of D2-SPN dendrites and synapses and remodeling of cortical and fast-spiking interneuron inputs ([@R13]; [@R19]; [@R18]; [@R32]). Thus, in response to cortical input, D2-SPNs generate abnormally strong, phasic suppression of GPe activity at approximately the same time that the STN receives direct cortical excitation ([@R64]; [@R76]; [@R36]). In DA-intact mice, we found that chemogenetic stimulation of D2-SPNs was sufficient to downregulate autonomous STN activity, suggesting that the loss of autonomous STN activity in PD models is triggered by elevated D2-SPN output. Consistent with this mechanism, prior 6-OHDA lesioning occluded the downregulatory effect of chemogenetically stimulating D2-SPNs. Although the loss of dopaminergic neuromodulation within the STN ([@R74]; [@R34]; [@R47]) cannot be completely excluded as a factor, the extent to which STN activity was downregulated in PD mice was reproduced solely by D2-SPN stimulation in DA-intact mice. Furthermore, DA receptor antagonist application has no effect on autonomous STN activity in *ex vivo* brain slices from DA-intact mice ([@R61]; [@R34]).

The proposition that disinhibition of the STN leads to downregulation of autonomous spiking is consistent with our observation that KD of STN NMDARs completely prevented the effect of DA depletion on autonomous STN activity. Furthermore, the ability of NMDAR stimulation to suppress STN spiking *ex vivo* ([@R4]) was occluded in slices from 6-OHDA-lesioned mice, suggesting that this mechanism had already been engaged *in vivo*. These data, together with recent studies of synaptic excitation ([@R11]) and inhibition ([@R12]), argue that both the level of autonomously generated STN activity *and* the balance of synaptic excitation and inhibition of STN neurons are regulated by the level of STN NMDAR activation *in vivo*.

How do NMDARs regulate autonomous STN activity? NMDAR activation can stimulate mitochondrial respiration through several mechanisms, including mitochondrial Ca^2+^ loading and/or reducing the cytosolic ATP to ADP ratio, leading to an increase in the production of ROS ([@R15]; [@R58]). Consistent with this mechanism, mitochondrial matrix oxidant stress was elevated in STN neurons from 6-OHDA-injected mice. This effect could also be mimicked in STN neurons from DA-intact mice by pre-incubation of slices in exogeneous NMDA. Elevated mitochondrial oxidant stress can impair ATP production and could therefore limit autonomous firing through an ATP-dependent mechanism ([@R65]). However, we found that dialysis of STN neurons with ATP did not rescue autonomous activity. Instead, breakdown of the ROS hydrogen peroxide rapidly reversed autonomous firing deficits in slices from DA-depleted mice. K~ATP~ channels are key metabolic sensors that limit cellular excitability in response to oxidative stress and/or a reduction in the ATP-to-ADP ratio ([@R44]; [@R31]). In DA-depleted mice, inhibition of K~ATP~ channels restored autonomous STN activity and occluded the effect of hydrogen peroxide breakdown. Because hydrogen peroxide directly promotes K~ATP~ channel opening ([@R26]; [@R31]) and its breakdown rapidly reversed firing deficits, it appears to be directly responsible for increased K~ATP~ channel activation in STN neurons from PD mice, rather than, e.g., RNS-dependent modulation ([@R27]; [@R55]). Indeed, in DA-intact mice elevation of hydrogen peroxide through inhibition of glutathione peroxidase reduces the rate of autonomous STN activity through activation of K~ATP~ channels ([@R4]). Interestingly, inhibition of K~ATP~ channels also restored autonomous firing following chemogenetic stimulation of D2-SPNs in DA-intact mice, pointing to the engagement of a common mechanism of downregulation in response to D2-SPN hyperactivity. Precisely why ROS levels and K~ATP~ channel activation remain persistently elevated in *ex vivo* brain slices is unclear, but possible mechanisms include (1) increased ROS production by mitochondria because of damage to electron transport chain proteins ([@R1]; [@R65]); (2) compromised antioxidant defense ([@R65]); and (3) long-term modification of K~ATP~ channel gating and expression ([@R56]).

NMDAR-dependent STN plasticity appears to be maladaptive in the 6-OHDA model of late-stage PD because its obstruction through STN NMDAR KD prevented motor dysfunction ([@R12]). Also consistent with the maladaptive nature of STN plasticity is our demonstration that the chemogenetic rescue of autonomous firing improves motor function in PD mice. It would be interesting to know when, and to what degree, cellular and synaptic STN plasticity are engaged during the progressive degeneration of DA neurons in PD. STN plasticity may become progressively extreme and track the emergence of motor symptoms as DA neurons degenerate. Alternatively, STN plasticity may be compensatory initially and engaged maximally prior to motor dysfunction. Increasingly, pathological upstream activity in conjunction with aberrant cellular and synaptic STN properties may then contribute to symptomatic onset. In this circumstance, chemogenetic restoration of autonomous firing could be therapeutic because it opposes the pathological patterning of STN activity by the hyper-direct and -indirect pathways ([@R36]; [@R59]). Consistent with this mechanism, we found that the impact of hyperdirect pathway cortical inputs *ex vivo* was largely vetoed by chemogenetically created intrinsic STN activity. Chemogenetic elevation of autonomous STN firing and output could also oppose Parkinsonian indirect pathway activity by modifying the impact of GPe inhibitory synaptic inputs on STN activity ([@R8]; [@R68]) *and* counteracting the excessive inhibitory synaptic patterning of prototypic GPe neurons by D2-SPNs ([@R64]; [@R76]; [@R36]). Indeed, STN NMDAR KD, which also ameliorates motor dysfunction, largely disconnects the indirect pathway by downregulating GPe-STN transmission ([@R11]). Interruption of Parkinsonian hyperdirect and indirect pathway activity may ultimately explain why diverse STN manipulations---including lesioning ([@R6]); optogenetic or pharmacological silencing ([@R33]; [@R70]); high-frequency optogenetic stimulation of afferents ([@R20]; [@R51]); direct high-frequency electrical stimulation ([@R5]; [@R67]); genetic manipulation ([@R75]); and chemogenetic elevation of autonomous activity---are therapeutic. Ultimately, simultaneous, large-scale measurement of neuronal activity throughout the cortico-basal ganglia-thalamo-cortical circuit will be necessary to determine why such radically different manipulations of the STN exhibit therapeutic efficacy in PD and its experimental models.

STAR★METHODS {#S9}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S10}
---------------------------------------

Further information and requests for resources and reagents should be directed to the Lead Contact, Mark Bevan (<m-bevan@northwestern.edu>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S11}
--------------------------------------

Experiments were performed using naive adult male C57BL/6 (RRID:IMSR_JAX:000664; age = 76, 70-92 days; n = 152), B6.129S4-*Grin1^tm2Stl^*/J (RRID:IMSR_JAX:005246; age = 89, 82-198 days; n = 9), B6.Cg-Tg(Adora2a-Chrm3\*,-mCherry)AD6Blr/J (RRID:IMSR_JAX:017863; age = 125, 87-205 days; n = 18), and Tg(Gabrr3-cre)KC112Gsat (RRID:MGI:5528400; age = 68 days; n = 2) mice ([Table S8](#SD1){ref-type="supplementary-material"}) according to Northwestern University Feinberg School of Medicine IACUC and NIH guidelines for the care and use of animals. Mice were housed singly or with up to 4 other littermates per cage under a 14-hour light, 10-hour dark cycle with food and water *ad libitum*, and were inspected daily by Northwestern University Feinberg School of Medicine animal care technicians, veterinarians, and laboratory staff. Where possible littermates were assigned evenly to different treatment groups.

METHOD DETAILS {#S12}
--------------

### Surgery {#S13}

6-OHDA, vehicle, and viral vectors were injected stereotaxically (Neurostar, Tubingen, Germany) under (1%--2%) isoflurane anesthesia (Smiths Medical ASD, Inc., Dublin, OH, USA). 6-OHDA (3-4 mg/ml) or vehicle was injected unilaterally into the medial forebrain bundle (MFB; from Bregma: AP −0.7 mm, ML +1.2 mm, DV +4.7 mm; 1.5 μl) to lesion midbrain DA neurons or control for injection, respectively. Pargyline (50 mg/kg) and desipramine (25 mg/kg) were used to increase the potency and specificity of 6-OHDA, respectively. In C57BL/6 mice AAV expressing hSyn-ChR2(H134R)-eYFP (AAV9.hSyn.hChR2(H134R)-eYFP.WPRE.hGH; 1 × 10^13^ GC/ml; University of Pennsylvania Viral Vector Core) was injected at 3 sites in primary motor cortex (AP +0.6 mm, +1.2 mm, and +1.8 mm, ML +1.5 mm, DV +1.0 mm; 300 nL per site), or AAV expressing CMV-mito-roGFP (AAV9-CMV-mito-roGFP-SV40; 2.5 × 10^12^ GC/ml; Virovek Inc., Hayward, CA), or hSyn-HA-hM3D(Gq)-IRES-mCitrine (AAV2/5-hSyn-HA-hM3D(Gq)-IRES-mCitrine; 2 × 10^12^ GC/ml) or hSyn-hM3D(Gq)-mCherry (AAV8-hSyn-hM3D(Gq)-mCherry; 0.5-3 × 10^12^ GC/ml; UNC Vector Core, Chapel Hill, NC or Addgene, Cambridge, MA) was injected in the STN (AP −2.06 mm, ML +1.4 mm, DV +4.45 mm; 300-500 nl), ipsilateral to the MFB injection. In *Grin1^lox/lox^* mice AAV expressing eGFP (AAV9-hSyn-eGFP-WPRE-bGH; 2 × 10^12^ GC/ml; University of Pennsylvania Viral Vector Core) or cre-eGFP (AAV9-hSyn-HI-eGFP-Cre-WPRE-SV40; 2 × 10^12^ GC/ml; University of Pennsylvania Viral Vector Core) was injected in the STN (AP −2.06 mm, ML +1.4 mm, DV +4.45 mm; 150-300 nl) ipsilateral to the MFB injection. Gabrr3-cre mice, in which there is cre-recombinase expression in STN neurons and minimal expression in adjacent structures, were injected with AAV expressing cre-dependent hSyn-DIO-hM3D(Gq)-mCherry (AAV8-hSyn-DIO-hM3D(Gq)-mCherry; 2--3 × 10^12^ GC/ml; UNC Vector Core, Chapel Hill, NC) in the STN. Finally, a subset of C57BL/6 mice were injected with AAV8-hSyn-hM3D(Gq)-mCherry dorsal to the STN (AP −2.06, ML +1.4, DV +3.75) to test the behavioral effects of hM3D(Gq) activation of structures adjacent to the STN. Electrophysiological, imaging and behavioral measurements were made 20, 16-22 days (n = 173) after surgery ([Table S8](#SD1){ref-type="supplementary-material"}).

### Electrophysiology {#S14}

Animals were first anesthetized through IP injection of ketamine/xylazine (87/13 mg/kg) and then transcardially perfused with ice-cold sucrose-based artificial cerebro-spinal fluid (sACSF: 230 mM sucrose, 2.5 mM KCl, 1.25 mM NaH~2~PO~4~, 0.5 mM CaCl~2~, 10 mM MgSO~4~, 10 mM glucose, and 26 mM NaHCO~3~), equilibrated with 95% O~2~ and 5% CO~2~. The brain was then removed and sectioned at 250 μm in the parasagittal plane at 30 μm/s in a chamber containing ice-cold sACSF using a vibratome (VT1200S; Leica Microsystems Inc., Buffalo Grove, IL, USA). Cut slices were transferred to ACSF (126 mM NaCl, 2.5 mM KCl, 1.25 mM NaH~2~PO~4~, 2 mM CaCl~2~, 2 mM MgSO~4~, 10 mM glucose, 26 mM NaHCO~3~, 1 mM sodium pyruvate, and 5 μM L-glutathione), equilibrated with 95% O~2~ and 5% CO~2~ at 35°C for 30 minutes and then held in ACSF at room temperature until recording.

In the recording chamber slices were perfused at a rate of 4-5 ml/min with synthetic interstitial fluid (SIF: 126 mM NaCl, 3 mM KCl, 1.25 mM NaH~2~PO~4~, 1.6 mM CaCl~2~, 1.5 mM MgSO~4~, 10 mM glucose and 26 mM NaHCO~3~), equilibrated with 95% O~2~ and 5% CO~2~ at 35°C. A microscope (Axioskop FS2 microscope (Carl Zeiss, Oberkochen, Germany) equipped with a LUMPlanFl/IR 60 × 0.9 NA objective (Olympus, Tokyo, Japan) or a BX51WI microscope (Olympus) equipped with a UIS2 LUMPFL 60 × 0.9 NA objective (Olympus)) employing infrared Dodt Gradient Contrast illumination (Luigs & Neumann, Ratingen, Germany) was used to visualize cell bodies for patch clamp recording. 590 nm LED illumination (Cairn Instruments, Faversham, Kent, UK) was used to identify neurons expressing hM3D(Gq)-mCherry and 890 nm 2-photon illumination (Mira 900F and G8 532 nm OPSL pump laser, Coherent Inc., Santa Clara, USA; as for mito-roGFP imaging, detailed below) was used to identify neurons expressing eGFP or cre-eGFP.

Recordings were obtained using computer-controlled manipulators (Luigs & Neumann) and a Multiclamp 700B amplifier, and a Digidata 1440A digitizer controlled by PClamp10 (Molecular Devices, Sunnyvale, CA, USA). Signals were low-pass filtered online at 10 kHz and sampled at 50 kHz. Cell and electrode capacitance, series resistance, and junction potential were compensated electronically. Recordings utilized borosilicate glass pipettes (Warner Instruments, Hamden, CT, USA) pulled using a P-97 Flaming/Brown Micropipette Puller (Sutter Instruments, Novato, CA, USA). Loose-seal cell-attached recordings were made with 3-5 MΩ impedance pipettes containing HEPES-buffered SIF solution (HBS: 140 mM NaCl, 23 mM glucose, 15 mM HEPES, 3 mM KCl, 1.5 mM MgCl~2~, 1.6 mM CaCl~2~; pH 7.2 with NaOH; 300--310 mOsm/L). Cell-attached recordings were excluded if the membrane became disrupted. Whole-cell voltage clamp recordings were made using 4-5 MΩ impedance pipettes filled with a K-gluconate-based internal solution (140 mM K-gluconate, 3.8 mM NaCl, 1 mM MgCl~2~, 10 mM HEPES, 0.1 mM Na~4~-EGTA, 0.4 mM Na~3~GTP, and 2 mM Mg~1.5~ATP). Voltage clamp recordings were excluded if series resistance changed by more than 20% during the course of recording. Whole-cell current clamp recordings were made using 12-15 MΩ impedance pipettes filled with KCH~3~SO~4~-based internal solution (130 mM KCH~3~SO~4~, 3.8 mM NaCl, 1 mM MgCl~2~, 10 mM HEPES, 5 mM phosphocreatine, 0.1 mM Na~4~-EGTA, 0.4 mM Na~3~GTP, and 2 mM Mg~1.5~ATP).

Optogenetic stimulation was delivered via the objective lens using a 470 nm light emitting diode (OptoLED; Cairn Research, Faversham, Kent, UK). Cortico-STN transmission was evoked by 1 ms duration optogenetic stimulation of cortico-STN axon-terminals. EPSCs and IPSCs were also evoked by electrical stimulation of the internal capsule bordering the rostro-ventral STN using a constant current isolator (A365R, World Precision Instruments, Sarasota, FL). The poles of stimulation were selected from a custom-built matrix of 10 stimulation electrodes (MX52CBWMB2, Frederick Haer, Bowdoin, ME).

Autonomous activity was typically recorded in the presence of 20 μM DNQX, 50 μM D-APV, 10 μM SR-95531, and 2 μM CGP55845 (Abcam, Cambridge, MA, USA) to antagonize AMPARs, NMDARs, GABA~A~Rs and GABA~B~Rs, respectively. DNQX and D-APV were excluded when the response of STN neurons to optogenetic cortico-STN stimulation or electrically evoked EPSCs were studied. SR-95531 and CGP55845 were excluded when electrically evoked IPSCs were studied. The effect of catalase (polyethylene glycolcatalase; 250 U/mL; Sigma-Aldrich), glibenclamide (100 nM; Sigma-Aldrich), apamin (10 nM; Sigma-Aldrich), or CNO (10-100 μM; Sigma-Aldrich) on firing was also studied.

### 2-Photon Imaging of mito-roGFP {#S15}

Brain slices were prepared from mice expressing the mitochondrially-targeted redox-sensitive probe mito-roGFP in STN neurons, as for electrophysiology. mito-roGFP-expressing neurons were imaged at 890 nm with 76 MHz pulse repetition and \~250 fs pulse duration at the sample plane. Two-photon excitation was provided by a G8 OPSL pumped Mira 900 F laser (Coherent, Santa Clara, CA, USA). Sample power was regulated by a Pockels cell electro-optic modulator (model M350-50-02-BK, Con Optics, Danbury, CT, USA). Images were acquired using an Ultima 2 P system running *PrairieView* 5.3 (Bruker Nano Fluorescence Microscopy, Middleton, WI, USA) and a BX51WI microscope (Olympus, Tokyo, Japan) with a 60 × 0.9 NA objective (UIS2 LUMPFL; Olympus). Mito-roGFP fluorescence and simultaneous laser-scanned Dodt contrast images were acquired from each field of STN neurons in the presence of 20 μM DNQX, 50 μM APV, 10 μM SR-95531, and 2 μM CGP55845 under baseline conditions, following the addition of 2 mM dithiothrietol (DTT) to fully reduce the tissue, and following the addition of 200 μM aldrithiol (ALD) to fully oxidize the tissue ([@R50]; [@R4]). Average fluorescence intensities of mitochondria in STN neurons under baseline (F), reduced (F~DTT~), and oxidized (F~ALD~) conditions were quantified using ImageJ (NIH, Bethesda, MD, USA). Mitochondrial measurements were restricted to the somata of STN neurons through registration of mito-roGFP image and Dodt contrast images ([Figure 4A](#F4){ref-type="fig"}). Baseline mitochondrial oxidation in STN neurons was expressed relative to that under conditions of minimum and maximum oxidation from the Equation 1−\[(*F* − *F*~ALD~)/(*F*~DTT~ − *F*~ALD~)\].

### Behavioral Testing {#S16}

To assess forelimb usage during vertical exploration, animals were placed in a 600 mL cylindrical glass beaker (9.5 cm diameter; 12 cm height) and imaged using an HD digital camcorder recording at 60 fps (VIXIA HF R40 Full HD Camcorder; Canon, Melville, NY, USA). Forelimb placements on the vertical walls of the beaker were counted manually during video review ([@R52]). Placement of the left and right forepaw were considered simultaneous ("both") if they occurred within 3 frames of each other (i.e., \< 33 ms apart). Mice expressing hM3D(Gq)-mCherry were tested \~20-60 minutes following SC injection of vehicle or 1 mg/kg clozapine-n-oxide (CNO) or in the absence of an injection.

### Histology {#S17}

In order to study the expression of ChR2(H134)-eYFP, rM3D(Gs)-mCherry, cre-eGFP, eGFP, mito-roGFP, hM3D(Gq)-mCherry, *c-fos*, NeuN, PV, and TH, brain tissue was first fixed in 4% paraformaldehyde in 0.1 M phosphate buffer, pH7.4. Tissue prepared for electrophysiology or mito-roGFP imaging was immersion-fixed. Mice used for behavioral analyses were perfused-fixed under deep anesthesia (IP: 87 mg/kg ketamine, 13 mg/kg xylazine). Tissue was held in fixative at 4°C for at least 12 hours before rinsing in phosphate buffered saline (PBS; 0.05 M; pH 7.4). Tissue exceeding 250 μm in thickness was re-sectioned at 70 μm using a vibratome (Leica VT1000S; Leica Microsystems Inc.). Immunohistochemical detection of *c-fos*, NeuN, PV, and TH was carried out in PBS containing 0.5% Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA) and 2% normal donkey serum (Jackson ImmunoResearch, West Grove, PA, USA). Tissue was incubated in primary antibodies for 48-72 hours at 4°C or overnight at RT (rabbit anti-*c-fos*: 1:500 dilution; cat\# 2250S; Cell Signaling Technology, Danvers, MA; mouse anti-NeuN: 1:200 dilution; cat\# MAB377; EMD Millipore, Darmstadt, Germany; guinea pig anti-PV: 1:1,000; cat\# 195 004; Synaptic Systems, Gottingen, Germany; mouse anti-TH: 1:500 dilution; cat\# MAB318; EMD Millipore), washed in PBS, and then incubated in their respective secondary antibodies (donkey anti-rabbit Alexa Fluor 488: dilution 1:250; cat \# 711-545-152; Jackson ImmunoResearch; donkey anti-mouse Alexa Fluor 488: dilution 1:250; cat \# 715-545-150; Jackson ImmunoResearch; donkey anti-mouse Alexa Fluor 594: dilution 1:250; cat \# 715-585-150; Jackson ImmunoResearch; donkey anti-guinea pig Alexa Fluor 647: dilution 1:250; cat \# 706-605-148; Jackson ImmunoResearch) for 90-120 minutes at room temperature before a final wash with PBS. All tissue was mounted on glass slides using ProLong Diamond Antifade Reagent (ThermoFisher Scientific, Waltham, MA, USA) and coverslipped. Sections were imaged using an Axioskop 2 microscope (Carl Zeiss) equipped with a Neurolucida system (MBF Bioscience, Williston, VT, USA) and/or a confocal laser scanning microscope (A1R; Nikon, Melville, USA).

The densities of *c-fos*-positive neurons were assessed using NIH ImageJ and quantified using the optical dissector method ([@R66]). Confocal images were collected using a 60X, 1.4NA oil immersion Plan Apo objective lens on a Nikon A1R confocal microscope (0.205 micron/pixel; Nikon, Melville, USA). Sample sites were chosen using a grid (frame size, 50 × 50 μm) superimposed randomly on each image stack. Stereological counting commenced and was terminated at an optical section 5 μm and 21 μm below the slice surface, respectively. Look-up and reference planes were separated by 2 μm. Dopaminergic innervation was assessed from striatal TH immunoreactivity ([Table S8](#SD1){ref-type="supplementary-material"}), as described previously ([@R12]).

QUANTIFICATION AND STATISTICAL ANALYSIS {#S18}
---------------------------------------

Only data that were compromised by technical failure (e.g., failure of viral expression or immunohistochemical detection) were excluded. Each dataset, together with the associated number and type of observations, and the statistical tests that were applied are summarized in [Tables S1](#SD1){ref-type="supplementary-material"}-[S8](#SD1){ref-type="supplementary-material"}. In addition, paired data points or box-and-whisker plots displaying medians and inter-quartile and 10%--90% ranges calculated in Prism 7 (GraphPad Software, Inc., La Jolla, CA) are displayed in their respective figures to reflect the distribution and central tendency of the data. To minimize assumptions concerning the distribution of the data, exact, non-parametric (two-sided) statistics were used throughout: the Mann-Whitney U (MWU) test for unpaired data, the Wilcoxon signed rank (WSR) test for paired comparisons, and Fisher's exact test for contingency analyses. To ensure our experiments were adequately powered sample sizes for MWU and WSR tests were estimated to achieve a minimum of 80% power. For the MWU test, a 50^th^ percentile difference in median requires 10 samples. For the WSR test, if all pairs exhibit the same direction of change at least 6 observations are required. Exact p values were calculated using the fisher.test and the Wilcox.exact function (exactRankTests package) in R (<http://www.r-project.org>). Where datasets were subjected to multiple comparisons the p value was adjusted to maintain the family-wise error rate at 0.05 using the Holm-Bonferroni method (notated p~h~; [@R25]).

DATA AND CODE AVAILABILITY {#S19}
--------------------------

The data associated with this paper have been deposited on the Open Science Framework: <https://doi.org/10.17605/OSF.IO/7KWD2>.
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![The Autonomous Activity of STN Neurons Was Downregulated in 6-OHDA-Injected, DA-Depleted Mice\
(A and B) ChR2(H134R)-eYFP expression (green) and tyrosine hydroxylase (TH) immunoreactivity (red) ipsilateral (A) and contralateral (B) to injections of an AAV vector expressing ChR2(H134R)-eYFP in the primary motor cortex (M1) and 6-OHDA in the MFB.\
(C) ChR2(H134R)-eYFP (green) expressing cortico-STN axon terminals in the vicinity of NeuN-immunoreactive (red) neurons (asterisks) in the ipsilateral STN.\
(D and E) The frequency, regularity, and incidence of autonomous activity in STN neurons that receive motor cortical input was reduced in slices from DA-depleted mice (D, examples; D insets, response to optogenetic stimulation (blue) of motor cortical input; E, population data).\
\*p \< 0.05.\
See also [Figure S1](#SD1){ref-type="supplementary-material"} and [Table S1](#SD1){ref-type="supplementary-material"}.](nihms-1535579-f0002){#F1}

![Chemogenetic Aactivation of D2-SPNs Was Sufficient to Downregulate Autonomous STN Activity in DA-Intact Mice but This Effect Was Occluded in DA-Depleted Mice\
(A) Schedule of s.c. CNO or vehicle injection and *ex vivo* electrophysiological recording in adora2a-rM3D(Gs)-mCherry mice.\
(B) Expression of rM3D(Gs)-mCherry (red) in a subset of NeuN-immunoreactive striatal neurons (green) in an adora2a-rM3D(Gs)-mCherry mouse (arrows, expressing; asterisks, non-expressing).\
(C and D) Autonomous STN activity was downregulated in slices from CNO-treated mice (C, examples; D, population data).\
(E and F) In MFB vehicle-injected adora2a-rM3D(Gs)-mCherry mice, autonomous STN activity was downregulated in slices from CNO- compared to vehicle-treated mice. However, in MFB 6-OHDA-injected adora2a-rM3D(Gs)-mCherry mice, autonomous STN activity was downregulated in slices from both CNO- and vehicle-treated mice, arguing that the effect of chemogenetic stimulation of D2-SPNs was occluded by DA depletion (E, examples; F, population data).\
\*p \< 0.05. ns, not significant.\
See also [Table S2](#SD1){ref-type="supplementary-material"} and [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1535579-f0003){#F2}

![Downregulation of Autonomous STN Activity in DA-Depleted Mice Was Dependent on STN NMDAR Activation *In Vivo*\
(A and B) Confocal micrographs of viral-mediated eGFP (A, green) or cre-eGFP (B, green) expression in NeuN-immunoreactive (red) STN neurons (arrowheads) in *Grin1*^*lox/lox*^ mice.\
(C and D) In eGFP-expressing, NMDAR-intact STN neurons autonomous activity was downregulated in slices from 6-OHDA-injected mice. However, in cre-eGFP-expressing, NMDAR KD STN neurons autonomous firing was normal in slices from 6-OHDA-injected mice (C, examples; D, population data).\
(E and F) Activation of STN NMDARs *ex vivo* downregulated autonomous firing in slices from vehicle-injected, NMDAR-intact mice but its effects were occluded in slices from 6-OHDA-injected, NMDAR-intact mice. As expected, the autonomous firing of STN neurons in untreated slices from 6-OHDA-injected, NMDAR-intact mice was downregulated relative to that in untreated slices from vehicle-injected, NMDAR-intact mice (E, examples; F, population data).\
\*p \< 0.05. ns, not significant.\
See also [Table S3](#SD1){ref-type="supplementary-material"}.](nihms-1535579-f0004){#F3}

![STN Neurons Exhibited Elevated Mitochondrial Oxidant Stress and Hydrogen Peroxide-Triggered K~ATP~ Channel Activation in PD Mice\
(A) The expression of mito-roGFP (green) in STN neurons (arrowheads) and their somatic morphology (grayscale) were imaged under simultaneous 2-photon laser scanning fluorescent and Dodt contrast microscopy, respectively.\
(B) The relative oxidation of mitochondria in STN neurons was elevated in slices from 6-OHDA- versus vehicle-injected mice.\
(C and D) Breakdown of hydrogen peroxide with catalase rescued autonomous STN activity in slices from 6-OHDA-injected mice but had relatively minimal effects on neurons from vehicle-injected mice (C, examples; D, population data, catalase-associated changes).\
(E and F) Inhibition of K~ATP~ channels with glibenclamide rescued autonomous STN activity in slices from 6-OHDA-injected mice but had relatively minimal effects on neurons from vehicle-injected mice (E, examples; F, population data, glibenclamide-associated changes).\
(G) Autonomous firing in slices from 6-OHDA-injected mice that had been treated with glibenclamide or catalase were not significantly different from autonomous firing in slices from DA-intact control mice ([Figures 1C](#F1){ref-type="fig"} and [1D](#F1){ref-type="fig"}).\
(H and I) The effect of catalase on autonomous STN firing in slices from 6-OHDA-injected mice was occluded by prior application of glibenclamide (H, population data; I, example).\
(J and K) In slices from vehicle- or 6-OHDA-injected mice, autonomous STN activity first recorded in the cell-attached configuration was not altered by subsequent establishment of the whole-cell configuration with pipettes containing 2 mM of ATP (J, examples; K, population data).\
\*p \< 0.05. ns, not significant.\
See also [Figures S2](#SD1){ref-type="supplementary-material"} and [S3](#SD1){ref-type="supplementary-material"} and [Table S4](#SD1){ref-type="supplementary-material"}.](nihms-1535579-f0005){#F4}

![Chemogenetic Activation of hM3D(Gq)-mCherry in STN Neurons Augmented Their Intrinsic Activity\
(A) Confocal micrograph of hM3D(Gq)-mCherry expression (red) in NeuN-immunoreactive STN neurons.\
(B and C) Chemogenetic activation of hM3D(Gq)-mCherry with 10 μM of CNO generated a persistent inward current in STN neurons that were voltage clamped at −60 mV in *ex vivo* brain slices prepared from 6-OHDA- (green) or vehicle- (black) injected mice (B, example from a 6-OHDA-injected mouse; C, population).\
(D and E) Chemogenetic activation of hM3D(Gq)-mCherry increased the frequency and regularity of autonomous STN activity *ex vivo* (D, example from a 6-OHDA-injected mouse; E, population, black and green from vehicle- and 6-OHDA-injected mice, respectively).\
(F and G) Pairs of inhibitory postsynaptic currents (iPSCs; upper black and red traces; holding voltage, −60 mV) and excitatory synaptic currents (EPSCs; lower black and red traces; holding voltage, −80 mV) electrically evoked in STN neurons with an interval of 100 ms were unaffected by chemogenetic activation (F, examples from a 6-OHDA-injected mouse; G, population data, black and green from vehicle- and 6-OHDA-injected mice, respectively).\
(H--J) The patterning of STN activity by motor cortical inputs optogenetically stimulated at 20 Hz for 1 s (blue) in *ex vivo* brain slices from 6-OHDA-injected mice was reduced following chemogenetic rescue of intrinsic activity (H, example cell-attached recordings; I, population peristimulus time histogram \[magenta line, pre-stimulus mean; cyan line, pre-stimulus mean + 3 SD\]; J, population data; data were derived from 5 trials of stimulation per neuron). APs, action potentials.\
\*p \< 0.05. ns, not significant.\
See also [Table S5](#SD1){ref-type="supplementary-material"}.](nihms-1535579-f0006){#F5}

![Chemogenetic Activation of STN Neurons *In Vivo* Increased Immediate Early Gene Expression in the STN and Its Targets\
(A--C) The density of hM3D(Gq)-mCherry-expressing STN neurons that expressed*c-fos* was elevated in DA-intact and -depleted mice that were treated with CNO versus those treated with vehicle (A and B, examples; C, population data).\
(D--F) The density of PV-immunoreactive SN neurons that expressed *c-fos* was elevated in DA-intact and -depleted mice that were treated with CNO versus those treated with vehicle (D and E, examples; F, population data).\
\*p \< 0.05.\
See also [Table S6](#SD1){ref-type="supplementary-material"}.](nihms-1535579-f0007){#F6}

![Chemogenetic Activation of the STN Improved Motor Function in Unilateral 6-OHDA-Injected Mice\
(A) In unilateral 6-OHDA-injected mice (green) contralateral forelimb use during vertical exploration was lower than in DA-intact, vehicle-injected mice (black).\
(B and E) In vehicle-injected, DA-intact mice forelimb use was symmetric and not affected by chemogenetic activation (CNO) of hM3D(Gq)-mCherry expressed in the STN and zona incerta (ZI) (B, left panel, hM3D(Gq)-mCherry expression; B, right panel, population data, example highlighted).\
(C and E) In 6-OHDA-injected, DA-depleted mice forelimb usage was asymmetric but ameliorated by chemogenetic activation of hM3D(Gq)-mCherry expressed in the STN and ZI (C, left panel) or the STN alone (C, middle panel; expression was restricted to the STN in a GABRR3-cre mouse through injection of an AAV carrying a cre-dependent construct; C, right panel, population data with examples highlighted).\
(D and E) In 6-OHDA-injected, DA-depleted mice asymmetric forelimb use was moderately ameliorated by chemogenetic activation of hM3D(Gq)-mCherry expressed in the ZI (D, left panel, hM3D(Gq)-mCherry expression; D, right panel, population data, example highlighted).\
(E) However, the chemogenetic rescue of forelimb usage in 6-OHDA-injected mice was significantly greater when hM3D(Gq)-mCherry expression involved the STN.\
\*p \< 0.05. ns, not significant.\
See also [Table S7](#SD1){ref-type="supplementary-material"} and [Video S1](#SD1){ref-type="supplementary-material"}.](nihms-1535579-f0008){#F7}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                SOURCE                                     IDENTIFIER
  -------------------------------------------------- ------------------------------------------ -----------------------------------------
  Antibodies                                                                                    
  rabbit anti-c-fos                                  Cell Signaling Technology                  cat\#2250S; RRID:AB_2247211
  mouse anti-NeuN                                    EMD Millipore                              cat\#MAB377; RRID:AB_2298772
  guinea pig anti-PV                                 Synaptic Systems                           cat\#195004; RRID:AB_2156476
  mouse anti-TH                                      EMD Millipore                              cat\# MAB318; RRID:AB_2201528
  donkey anti-rabbit Alexa Fluor 488                 Jackson ImmunoResearch                     cat\#711-545-152; RRID:AB_2313584
  donkey anti-mouse Alexa Fluor 488                  Jackson ImmunoResearch                     cat\#715-545-150; RRID:AB_2340846
  donkey anti-mouse Alexa Fluor 594                  Jackson ImmunoResearch                     cat\#715-585-150; RRID:AB_2340854
  donkey anti-guinea pig Alexa Fluor 647             Jackson ImmunoResearch                     cat\#706-605-148; RRID:AB_2340476
  Bacterial and Virus Strains                                                                   
  AAV9.hSyn.hChR2(H134R)-eYFP.WPRE.hGH               U. Penn. Vector Core                       Addgene viral prep \# 26973-AAV9
  AAV9-CMV-mito-roGFP-SV40                           Virovek Inc.; [@R50]                       N/A
  AAV2/5-hSyn-HA-hM3D(Gq)-IRES-mCitrine              U.N.C. Vector Core                         discontinued
  AAV8-hSyn-hM3D(Gq)-mCherry                         Addgene                                    Addgene viral prep \# 50474-AAV8
  AAV9-hSyn-eGFP-WPRE-bGH                            U. Penn. Vector Core                       Addgene viral prep \# 105539-AAV9
  AAV9.hSyn.HI.eGFP-Cre.WPRE.SV40                    U. Penn. Vector Core                       Addgene viral prep \# 105540-AAV9
  AAV8-hSyn-DIO-hM3D(Gq)-mCherry                     Addgene; [@R29]                            Addgene viral prep \# 44361-AAV8
  Chemicals, Peptides, and Recombinant Proteins                                                 
  Apamin                                             Sigma-Aldrich                              Cat\#A9459
  Catalase-polyethylene glycol                       Sigma-Aldrich                              Cat\#C4963
  6-Hydroxydopamine hydrobromide                     Tocris Bioscience                          Cat\#2547
  CGP 55845 hydrochloride                            Abcam Inc                                  Cat\#ab120337
  Clozapine *N*-oxide                                Tocris Bioscience                          Cat\#4936
  D-APV                                              Abcam Inc                                  Cat\#ab120003
  Desipramine hydrochloride                          Sigma-Aldrich                              Cat\#P3900
  DNQX disodium salt                                 Abcam Inc                                  Cat\#ab120169
  Glibenclamide                                      Sigma-Aldrich                              Cat\#G0639
  L-Glutathione                                      Sigma-Aldrich                              Cat\#G4251
  N-Methyl D-aspartic acid                           Tocris Bioscience                          Cat\#0114
  Pargyline hydrochloride                            Sigma-Aldrich                              Cat\#P8013
  Sodium pyruvate                                    Sigma-Aldrich                              Cat\#P2256
  SR95531 (Gabazine)                                 Abcam Inc                                  Cat\#ab120042
  Deposited Data                                                                                
  Raw and analyzed data                              This paper                                 <https://doi.org/10.17605/OSF.IO/7KWD2>
  Experimental Models: Organisms/Strains                                                        
  C57BL/6 mice                                       The Jackson Laboratory                     RRID:IMSR_JAX:000664
  B6.Cg-Tg(Adora2a-Chrm3\*,-mCherry) AD6Blr/J mice   The Jackson Laboratory                     RRID:IMSR_JAX:017863
  B6.129S4-*Grin1*^*tm2Stl*^/J mice                  The Jackson Laboratory                     RRID:IMSR_JAX:005246
  Tg(Gabrr3-cre)KC112Gsat mice                       Mutant Mouse Resource & Research Centers   RRID:MGI:5528400
  Software and Algorithms                                                                       
  Clampfit (version 10.5)                            Molecular Devices                          N/A
  Igor Pro (version 6.37)                            Wavemetrics Inc                            RRID: SCR_000325
  Neurolucida (version 11.03)                        MBF Bioscience                             RRID: SCR_001775
  Neurolucida Explorer (version 11.08)               MBF Bioscience                             N/A
  NIH ImageJ (version 1.47)                          NIH                                        RRID: SCR_003070
  OriginPro (version 2015)                           OriginLab Co.                              RRID: SCR_014212
  pClamp (version 10.5)                              Molecular Device                           RRID: SCR_011323
  Prism (version 6.0h)                               Graphpad software Inc                      RRID: SCR_002798
  R (version 3.3.1)                                  <http://www.R-project.org/>                RRID: SCR_001905

###### Highlights

-   Autonomous subthalamic nucleus (STN) activity is downregulated after loss of dopamine

-   Elevated D2-striatal projection neuron transmission is sufficient for downregulation

-   Downregulation is dependent on activation of STN NMDA receptors and K~ATP~ channels

-   Chemogenetic restoration of autonomous spiking reduces Parkinsonian dysfunction in mice
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